InPen™ Smart Insulin Pen

Guess less. Live More.

InPen is the only FDA-cleared smart insulin pen system combining a reusable Bluetooth-enabled insulin pen with an intuitive mobile app to help people with type 1 or type 2 diabetes take the right amount of insulin at the right time.

• Tracks active insulin
• Dosing reminders
• Calculates personalized doses
• Dials in half-unit increments
• Automatically logs doses
• Creates shareable reports
• Compatible with Humalog, Novolog and Fiasp cartridges
• Lasts a full year with no need to charge

For Providers:

Click here to download the InPen Rx / Certificate of Medical Necessity form

Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.

Humalog® is a registered trademark of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S.

Important Safety Information: InPen™

The InPen™ is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenSafety.

All other brands are trademarks of a Medtronic company.

The Bluetooth® Wordmark and logos are owned by Bluetooth® SIG, Inc. and any use of such marks by Companion Medical, Inc. is under license. InPen™ logo is a trademark of Companion Medical.